Original article| Volume 41, ISSUE 12, P1151-1156, 1988

Serum sex hormone levels and myocardial infarction in the honolulu heart program. Pitfalls in prospective studies on sex hormones

      This paper is only available as a PDF. To read, Please Download here.


      It has been hypothesized that hyperestrogenemia may underlie myocardial infarction. As a test of this hypothesis, the serum estradiol and testosterone levels were estimated in samples collected prospectively from 96 male patients aged 52–74 years [mean age 60.8 ± 6.3 (SD)] who had had a myocardial infarction and from 96 matched control subjects in the Honolulu Heart Program. Established risk factors for myocardial infarction were measured prospectively. No significant difference between patients and control subjects in mean estradiol or testosterone level was observed. The only established risk factor that was significantly different was blood pressure, which was higher in the patients. Thus, the data did not confirm the hypothesis. However, two major pitfalls for prospective studies of estradiol in myocardial infarction, which might have affected the validity of the results, were observed, namely, deterioration of estradiol values with prolonged storage (8.5–12 years in this study) and intervention. The value of this study, therefore, may he in pointing out difficulties in carrying out prospective studies on sex hormones.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Clinical Epidemiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Phillips G.B.
        Evidence for hyperestrogenemia as a risk factor for myocardial infarction in men.
        Lancet. 1976; ii: 14-18
        • Phillips G.B.
        • Castelli W.P.
        • Abbott R.D.
        • McNamara P.M.
        Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort.
        Am J Med. 1983; 74: 863-869
        • Phillips G.B.
        Relationship between serum sex hormones and glucose, insulin, and lipid abnormalities in men with myocardial infarction.
        in: Proc Natn Acad Sci. 74. 1977: 1729-1733
        • Phillips G.B.
        Sex hormones, risk factors and cardiovascular disease.
        Am J Med. 1978; 65: 7-11
        • Heller R.F.
        • Jacobs H.S.
        • Vermeulen A.
        • Deslypere J.P.
        Androgens, oestrogens, and coronary heart disease.
        Br Med J. 1981; 282: 438-439
        • Winter J.H.
        • Wilson G.R.
        • Morley K.D.
        • Douglas A.S.
        Estradiol levels in myocardial infarction.
        Arch Intern Med. 1982; 142: 1581-1582
        • Kagan A.
        • Harris B.R.
        • Winkelstein Jr, W.
        • et al.
        Epidemiological studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics.
        J Chron Dis. 1974; 27: 345-364
        • Yano K.
        • Reed D.M.
        • Mcgee D.L.
        Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to biologic and lifestyle characteristics.
        Am J Epidemiol. 1984; 119: 653-666
        • Cauley J.A.
        • Gutai J.P.
        • Kuller L.H.
        • Dai W.S.
        Usefulness of sex steroid hormone levels in predicting coronary artery disease in men.
        Am J Cardiol. 1987; 60: 771-777
        • Phillips G.B.
        Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort (letter).
        Am J Med. 1985; 78: A64
        • Phillips G.B.
        Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohort (letter).
        Am J Med. 1985; 78: A76
        • Lindholm J.
        • Winkel P.
        • Brodthagen U.
        • Gyntelberg F.
        Coronary risk factors and plasma sex hormones.
        Am J Med. 1982; 73: 648-651
        • Klaiber E.L.
        • Broverman D.M.
        • Dalen J.E.
        Serum estradiol levels in male cigarette smokers.
        Am J Med. 1984; 77: 858-862
        • Stefanick M.L.
        • Williams P.T.
        • Krauss R.M.
        • Terry R.B.
        • Vranizan K.M.
        • Wood P.D.
        Relationships of plasma estradiol, testosterone, and sex hormone-binding globulin with lipoproteins, apolipoproteins, and high density lipoprotein subfractions in men.
        J Clin Endocrinol Metab. 1987; 64: 723-729
        • Barrett-Connor E.
        • Khaw K.
        Cigarette smoking and increased endogenous estrogen levels in men.
        Am J Epidemiol. 1987; 126: 187-192
        • Phillips G.B.
        Evidence for hyperestrogenemia as the link between diabetes mellitus and myocardial infarction.
        Am J Med. 1984; 76: 1041-1048
        • Small M.
        • MacRury S.
        • Beastall G.H.
        • MacCuish A.C.
        Oestradiol levels in diabetic men with and without a previous myocardial infarction.
        Q J Med. 1987; 243: 617-623
        • Girndt J.
        • Calkanis Z.
        • Kreuzer H.
        • Seidel D.
        • Scheler F.
        Östrogen als Risikofaktor für das Gefässsystem.
        Dtsch Med Wochenschr. 1980; 105: 1601-1603
        • Labropoulis B.
        • Velonakis E.
        • Oekonomakos P.
        • Laskaris J.
        • Katsimades D.
        Serum sex hormones in patients with coronary disease and their relationship to known factors causing atherosclerosis.
        Cardiology. 1982; 69: 98-103
        • Rosenthal M.B.
        • Barnard J.
        • Rose D.P.
        • Inkeles S.
        • Hall J.
        • Pritikin N.
        Effects of a high-complex carbohydrate, low-fat, low-cholesterol diet on levels of serum lipids and estradiol.
        Am J Med. 1985; 78: 23-27
        • Mendoza S.G.
        • Zerpa A.
        • Carrasco H.
        • Colmenares O.
        • Rangel A.
        • Gartside P.S.
        • Kashyap M.L.
        Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.
        Artery. 1983; 12: 1-23
        • Laskarzewski P.M.
        • Morrison J.A.
        • Gutai J.
        • Orchard T.
        • Khoury P.R.
        • Glueck C.J.
        High and low density lipoprotein cholesterols in adolescent boys: relationships with endogenous testosterone, estradiol, and Quetelet index.
        Metabolism. 1983; 32: 262-271
        • Schneider G.
        • Kirschner M.A.
        • Berkowitz R.
        • Ertel N.H.
        Increased estrogen production in obese men.
        J Clin Endocrinol Metab. 1979; 48: 633-638
        • Kley H.K.
        • Solbach H.G.
        • McKinnan J.C.
        • Krüskemper H.L.
        Testosterone decrease and oestrogen increase in male patients with obesity.
        Acta Endocrinol. 1979; 91: 553-563
        • Stanik S.
        • Dorfeld L.P.
        • Maxwell M.H.
        • Viosca S.P.
        • Korenman S.G.
        The effect of weight loss on reproductive hormones in obese men.
        J Clin Endocrinol Metab. 1981; 53: 828-832
        • Phillips G.B.
        • Yano K.
        • Stemmermann G.N.
        Decrease in serum estradiol values with storage (letter).
        N Engl J Med. 1984; 311: 1635
      1. Abraham GE. Personal communication.

        • Deslypere J.P.
        • Vermeulen A.
        Leydig cell function in normal men: effect of age, life-style, residence, diet, and activity.
        J Clin Endocrinol Metab. 1984; 59: 955-962
        • Faiman C.
        • Winter J.S.D.
        Diurnal cycles in plasma FSH, testosterone and cortisol in men.
        J Clin Endocrinol Metab. 1971; 33: 186-192